13F HOLDINGS REPORT
Euclidean Capital LLC
Quarter ended Q4 2025 · Filed February 17, 2026 · Accession 0001012975-26-000154
Total Value
$369.5M
Positions
12
Other Managers
0
Confidential Omitted
No
Holdings (12)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | VANGUARD INTL EQUITY INDEX F | 922042775 | 2,990,084 | $220.0M | 59.53% |
| 2 | VANGUARD INDEX FDS | 922908744 | 520,000 | $99.3M | 26.88% |
| 3 | ISHARES TR | 46429B598 | 369,600 | $20.0M | 5.41% |
| 4 | FOGHORN THERAPEUTICS INC | FHTX | 1,573,761 | $8.5M | 2.30% |
| 5 | ORIC PHARMACEUTICALS INC | ORIC | 989,410 | $8.1M | 2.19% |
| 6 | PMV PHARMACEUTICALS INC | PMVP | 2,627,643 | $3.3M | 0.89% |
| 7 | SPDR S&P 500 ETF TR | SPY | 4,104 | $2.8M | 0.76% |
| 8 | RAPT THERAPEUTICS INC | 75382E208 | 82,234 | $2.8M | 0.75% |
| 9 | ALECTOR INC | ALEC | 1,307,858 | $2.0M | 0.55% |
| 10 | SURROZEN INC | SRZNW | 87,696 | $2.0M | 0.54% |
| 11 | TENAYA THERAPEUTICS INC | TNYA | 1,015,705 | $722,674 | 0.20% |
| 12 | SURROZEN INC | SRZNW | 170,833 | $3,417 | 0.00% |